Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in elderly

Stella Dracheva1, Kenneth L Davis, Benjamin Chin

  • 1Department of Psychiatry, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029, USA.

Neurobiology of Disease
|October 11, 2005
PubMed

Insights

Schizophrenia is linked to oligodendrocyte and myelin-related (OMR) gene deficits, particularly in the hippocampus and anterior cingulate cortex. These deficits are brain-region specific, suggesting shared regulatory elements influence affected OMR genes.

Area of Science:

  • Neuroscience
  • Molecular Psychiatry
  • Genetics

Background:

  • Previous studies suggest oligodendrocyte and myelin-related (OMR) deficits in schizophrenia.
  • The precise magnitude and brain-region specificity of these deficits remain unclear.

Purpose of the Study:

  • To quantitatively assess OMR gene expression deficits in schizophrenia.
  • To determine the brain-region specificity of these deficits.
  • To investigate interrelationships among OMR gene expression levels.

Main Methods:

  • Quantitative analysis of mRNA expression for key OMR genes (MAG, CNP, SOX10, CLDN11, PMP22, MBP, MOBP).
  • Analysis of protein expression for CNP.
  • Brain tissue samples from the hippocampus, anterior cingulate cortex, and putamen of schizophrenia patients.
  • Correlation and factor analyses to examine gene expression interrelationships.

Main Results:

  • Reduced mRNA expression of MAG, CNP, SOX10, CLDN11, and PMP22 was observed in the hippocampus and anterior cingulate cortex, but not the putamen.
  • CNP protein expression was decreased in the hippocampus but not the putamen.
  • Genes with differential expression loaded onto separate factors, distinct from those without significant changes (MBP, MOBP).

Conclusions:

  • OMR gene and protein expression deficits in schizophrenia are brain-region specific.
  • Affected OMR genes may be influenced by shared regulatory elements.